NCT03150862 2025-02-04
A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma
BeiGene
Phase 1/2 Completed
BeiGene
DNAtrix, Inc.
Boehringer Ingelheim
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)